targeted molecular therapeutics

July 23, 2014

Leading Clinician-Scientist Joins UAMS Myeloma Institute

Spencer Watson

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has named internationally recognized clinician and researcher Faith Davies, M.D., a professor of medicine and the director of the Phase I Clinical Trials Program for both the Myeloma Institute and the Winthrop P. Rockefeller Cancer Institute.